Tab. VII.
Impact of the introduction of a QIV in Italy on influenza cases: base-case results.
| Current scenario | New or alternative scenario | Δ (avoided cases with new scenario) | |
|---|---|---|---|
| Subjects covered by vaccination | 9,539.315 | 9,539.315 | |
| With TIVs | 9,539.315 | 8,680.777 | |
| With QIV | 0 | 858,538 | |
| Influenza events without complications in immunized subjects | 255,703 | 254,102 | -1,601 |
| Influenza events with complications in immunized subjects | 166,596 | 165,565 | -1,031 |
| Bronchitis in immunized subjects | 69,924 | 69,491 | -433 |
| Pneumonia in immunized subjects | 6,351 | 6,312 | -39 |
| Upper respiratory tract infections (URTI) in immunized subjects | 74,944 | 74,481 | -464 |
| Other complications not related to respiratory tract in immunized subjects | 15,377 | 15,282 | -95 |
| Hospitalization in immunized subjects | 16,073 | 15,973 | -100 |